CA Patent

CA2590675A1 — Nanoparticulate tacrolimus formulations

Assigned to Perrigo Pharma International DAC · Expires 2006-06-22 · 20y expired

What this patent protects

The present invention is directed to nanoparticulate tacrolimus compositions. The composition comprising tacrolimus particles having an effective average particle size of less than about 2000 nm and at least one surface stabilizer.

USPTO Abstract

The present invention is directed to nanoparticulate tacrolimus compositions. The composition comprising tacrolimus particles having an effective average particle size of less than about 2000 nm and at least one surface stabilizer.

Drugs covered by this patent

Patent Metadata

Patent number: CA2590675A1
Jurisdiction: CA
Classification: —
Expires: 2006-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Perrigo Pharma International DAC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.